Our findings will not only contribute to further elucidating of the regulatory mechanisms of MVP in the progression and treatment of PAAD, but also provide new insights for developing new drugs suitable for PAAD patients and optimizing personalized therapeutic plans. Here, MVP is linked to pancreatic adenocarcinoma.